Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    " March 30, 2011":" April 29, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" March 30, 2011":" April 29, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
2 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
3 Terminated
Has Results
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
4 Completed Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
5 Completed Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
6 Unknown  Improving Antiretroviral Medication Adherence Among HIV-infected Youth
Condition: HIV Infection
Intervention: Behavioral: Positive STEPS
7 Completed
Has Results
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
Condition: HIV Infections
Interventions: Biological: TUTI-16 (1.0 mg);   Other: Placebo
8 Completed Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: empowerment theory-based small group discussion;   Behavioral: individual resilience counseling
9 Completed A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
10 Unknown  Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
11 Active, not recruiting
Has Results
Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir
12 Completed Microparticles, Vector of Genetic Information During HIV Infection
Condition: HIV,
Intervention: Biological: Blood samples
13 Completed
Has Results
Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Condition: Human Immunodeficiency Virus Infection
Intervention:
14 Completed
Has Results
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV;   Hepatitis C, Chronic;   HCV Coinfection
Intervention:
15 Completed Role of HIV on Glutathione Synthesis and Oxidative Stress
Conditions: HIV Infection;   Erythrocyte Glutathione Deficiency
Interventions: Dietary Supplement: Cysteine (as n-acetylcysteine) and glycine;   Dietary Supplement: Cysteine/glycine
16 Completed Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
17 Completed Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
Conditions: HIV Infections;   Central Nervous System Diseases;   Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine;   Drug: tenofovir-lamivudine-efavirenz
18 Completed
Has Results
Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
19 Recruiting Collection of Blood for Multiple Collaborative Studies
Condition: HIV
Intervention:
20 Completed TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.
Conditions: Hepatitis C;   HIV
Interventions: Drug: ETR/telaprevir;   Drug: TMC278/telaprevir;   Drug: telaprevir/ETR;   Drug: telaprevir/TMC278

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years